Search

everythinglearnresearchcommunity

for

Search:↓

Patients with chronic skin conditions on systemic treatments did not have worse COVID-19 outcomes and could resume their treatments after recovery.

Following treatment plans is crucial to prevent worsening skin and hair conditions.

The document is a detailed medical reference on skin and genetic disorders.

The document reviews key historical figures and discoveries in dermatology.

The document reports unique growth lines in a child after Stevens-Johnson syndrome, skin reaction from parsnips and sun in a girl, and itchy skin with xanthomas in a boy with Alagille syndrome.

Different connective tissue disorders have unique symptoms and treatments, with varying outcomes and often require ongoing care from a specialist.

COVID-19 can cause or worsen skin issues.

COVID-19 and its vaccines can cause various skin issues due to viral effects, immune responses, and stress.

COVID-19 can harm many body parts, not just the lungs.

Higher IL-31 levels are linked to worse itching in chronic kidney disease patients.

JAK inhibitors help with skin conditions but need more research on dosing and safety.

The 308-nm excimer laser is a promising treatment for vitiligo with varying success and mild side effects.

The European Society of Cutaneous Lupus Erythematosus created a questionnaire to standardize patient assessment and improve care for cutaneous lupus.

Anifrolumab effectively improved lupus headaches in a patient unresponsive to other treatments.

Careful monitoring is crucial to prevent JC virus reactivation in lupus patients treated with rituximab.

Anifrolumab helped some lupus patients reduce steroid use, but safety concerns remain.

Living with lupus as both a patient and doctor improved understanding and care for others.

Upadacitinib may help treat difficult cases of systemic lupus erythematosus.

Early diagnosis and treatment are crucial for CAPS, and Eculizumab can be effective.

Middle-aged women with dilated cardiomyopathy should be screened for antiphospholipid syndrome.

Early recognition and a team approach are crucial for managing diffuse alveolar hemorrhage in antiphospholipid syndrome.

Trans-esophageal echocardiography is crucial for accurately diagnosing heart issues in lupus patients.

Anifrolumab may help improve symptoms in patients with overlapping autoimmune diseases.

Proactive physical therapy improved mobility, reduced fatigue, and pain in lupus patients.

SLE can cause unusual gastrointestinal symptoms, and immunosuppressive therapy can be effective.

Lupus patients in Ghana face healthcare challenges, and the Oyemam Autoimmune Foundation is working to improve awareness and support.

Purpura fulminans can signal underlying autoimmune disorders, not just infections.

Antiphospholipid syndrome can severely damage adrenal glands, requiring early diagnosis and treatment.

Bullous lupus can cause severe esophageal issues but responds well to corticosteroids and azathioprine.

Anti-CD19 therapy may help treat SLE and NMOSD.